Figure 1 Development of i NKT cells in mice

Nov 20, 2014

10 likes | 134 Views

Figure 1 Development of i NKT cells in mice. Drennan, M. B. et al. (2010) Invariant natural killer T cells in rheumatic disease: a joint dilemma Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2009.261.

Share Presentation

Embed Code

Link

cells
nkt cells
doi 10
rheumatic disease
figure 1 development
2010 invariant natural killer

oprah-stafford

Download Presentation

Figure 1 Development of i NKT cells in mice

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Figure 1 Development of iNKT cells in mice Drennan, M. B. et al.(2010) Invariant natural killer T cells in rheumatic disease: a joint dilemma Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2009.261

The Expression of GAD in Beta Cells of NOD Mice is Required for the Development of Diabetes

The Expression of GAD in Beta Cells of NOD Mice is Required for the Development of Diabetes. Susannah A. Hill. Background. Diabetes is an autoimmune disease Diabetes my be prevented by suppressing an autoimmune response.

336 views • 21 slides

Supplementary Figure 1. AMD/LPS-interaction caused hepatotoxicity in mice

Tumor necrosis factor-alpha potentiates the cytotoxicity of amiodarone in Hepa1c1c7 cells: roles of caspase activation and oxidative stress Supplementary Figures Jingtao Lu *† , Kazuhisa Miyakawa ‡† , Robert A. Roth §† and Patricia E. Ganey §†,1 .

174 views • 4 slides

MICE Target Development

MICE Target Development. Chris Booth Sheffield 8 th June 2006. Progress since last Collaboration Mtg. Review of components Assembly tests at RAL in April Developments resulting from tests Increased effort for target Plans & schedule June to November. Components. Stator body

459 views • 30 slides

Frequency of COP cells in control mice (caALK2)

Frequency of COP cells in control mice (caALK2). Control mice: received Ade-Cre and cardiotoxin but no treatment Baseline: no injection. COP cells in patients with fractures. Objective - to measure the frequency of COP cells in patients with fracture(s)

146 views • 5 slides

CONDITIONAL KNOCKOUT OF P53 IN MESENCHYMAL CELLS OF MICE RESULTS IN OSTEOSARCOMAS

CONDITIONAL KNOCKOUT OF P53 IN MESENCHYMAL CELLS OF MICE RESULTS IN OSTEOSARCOMAS. PATRICK P. LIN, FENGHUA JIN, GUILLERMINO LOZANO November 13, 2004 Montreal, Canada. Introduction. P53. Tumor suppressor gene Most commonly mutated tumor suppressor Approximately 50% of all cancers

679 views • 42 slides

Intravital imaging of CTLs killing islet cells in diabetic mice

Intravital imaging of CTLs killing islet cells in diabetic mice Ken Coppieters , Natalie Amirian , Matthias von Herrath Published in Volume 122, Issue 1 J Clin Invest. 2012; 122(1):119–131.

588 views • 48 slides

Figure 1 Muscle sections from DMRV–hIBM mice

Figure 1 Muscle sections from DMRV–hIBM mice. Senior, K. (2009) Potential therapy for hereditary myopathy Nat. Rev. Neurol. doi:10.1038/nrneurol.2009.102.

135 views • 1 slides

Figure 1

a. d. b. e. c. f. Effect of different induction strength of one chaperone team at constant induction strength of the other chaperone. Figure 1. 80 66 47 40 35 29 17. 1 2 3 4. STD Streptokinase. Degraded Fragments ~35 kDa.

250 views • 6 slides

Figure I.

Figure I. + D-4F Sc D-4F. FPLC FXN 29 33 34 35 36 29 33 34 35 36. STOKES DIAMETER nm 17 12.2 10.4 8.2 7.1. 30K. HDL PEAK. HDL PEAK. C C P. C C P. Figure II. W. a. t. e. r. C. o. n. t. r. o. l. +. D. -. 4. F. [. n. m. ]. Second dimension. 9.

261 views • 10 slides

Development of B-cells

Development of B-cells. 1) Gene rearrangements produce highly variable antibody genes 2) Expression of surface immunoglobulin 3) Deletion or silencing of autoreactive B-cells. allelic exclusion.

923 views • 44 slides

Figure I

Figure I. 5. 4. 3. H] AA Released. EPT. Ang1-7. Ang1-9. 2. 3. [. 1. 0. BKan. 1 µ mol/L. 1 µ mol/L. 1 µmol/L. medium. 10 nmol/L. 10 nmol/L. 10 nmol/L.

123 views • 1 slides

Figure I.

Figure I. ON-LINE LEGENDS

117 views • 3 slides

Figure 6.2 The size range of cells

Figure 6.2 The size range of cells. All organisms are made of cells, the organism's basic unit of structure and function. Table 6.3 Different Types of Light Microscopy: A Comparison. Figure 6.4 Electron micrographs. Figure 6.5 Cell fractionation.

1.1k views • 42 slides

1. Optical matching in MICE

1. Optical matching in MICE. Ulisse Bravar University of Oxford 2 June 2004 Constraints Software MICE proposal mismatch MICE Note 49 (September 2004, Bob Palmer) New Coils from Mike Green MICE Stages IV and V Current issues. 2. Constraints.

287 views • 13 slides

Figure 1 Development and prognosis of ACLF

Figure 1 Development and prognosis of ACLF. Wang, F.-S. & Zhang, Z. (2013) How can acute-on-chronic liver failure be accurately identified? Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2013.72.

285 views • 1 slides

Figure I

A. N. Figure I. T. B. N. T. C. T. N.

79 views • 2 slides

Figure 6.4b Muscle cells.

Figure 6.4b Muscle cells. Figure 6.1a Movement of bones. Figure 6.1b Movement of bones. Figure 6.3 Muscle structure. Epimysium. Bone. Tendon. Blood vessel. Fascicle (wrapped by perimysium). Endomysium (between individual muscle fibers). Muscle fiber.

665 views • 24 slides

Figure 2 Energy expenditure of Vdr –/– mice

Figure 2 Energy expenditure of Vdr –/– mice. Bouillon, R. et al. (2013) Vitamin D and energy homeostasis—of mice and men Nat. Rev. Endocrinol. doi:10.1038/nrendo.2013.226.

118 views • 1 slides

Figure 1

Figure 1.

91 views • 1 slides

Figure 3 Models of i NKT cell activation in response to endogenous antigens

Figure 3 Models of i NKT cell activation in response to endogenous antigens. Drennan, M. B. et al. (2010) Invariant natural killer T cells in rheumatic disease: a joint dilemma Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2009.261.

150 views • 1 slides

Figure 2 Models of i NKT cell activation in response to exogenous antigens

Figure 2 Models of i NKT cell activation in response to exogenous antigens. Drennan, M. B. et al. (2010) Invariant natural killer T cells in rheumatic disease: a joint dilemma Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2009.261.

109 views • 1 slides

Figure 1 The timeline of development

Figure 1 The timeline of development. Knuesel, I. et al. (2014) Maternal immune activation and abnormal brain development across CNS disorders Nat. Rev. Neurol. doi:10.1038/nrneurol.2014.187.

98 views • 1 slides

More Related